{"id":"NCT02738138","sponsor":"AbbVie","briefTitle":"A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)","officialTitle":"A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection (EXPEDITION-2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-17","primaryCompletion":"2017-03-15","completion":"2017-06-07","firstPosted":"2016-04-14","resultsPosted":"2018-05-09","lastUpdate":"2021-07-13"},"enrollment":153,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus Infection","Human Immunodeficiency Virus Infection","Chronic Hepatitis C","Compensated Cirrhosis and Non-cirrhotics"],"interventions":[{"type":"DRUG","name":"ABT-493 coformulated with ABT-530","otherNames":["ABT-493 also known as glecaprevir","ABT-530 also known as pibrentasvir","MAVYRET"]}],"arms":[{"label":"ABT-493/ABT-530 for 8 weeks","type":"EXPERIMENTAL"},{"label":"ABT-493/ABT-530 for 12 weeks","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the efficacy and safety of ABT-493/ABT-530 in adults with chronic hepatitis C virus genotype 1-6 infection and human immunodeficiency virus-1 co-infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response 12 Weeks Post-treatment (SVR12)","timeFrame":"12 weeks after last dose of study drug","effectByArm":[{"arm":"ABT-493/ABT-530","deltaMin":98,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29566246","30977945","30868245","30529905"],"seeAlso":["http://rxabbvie.com"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":137},"commonTop":["FATIGUE","NAUSEA","VIRAL UPPER RESPIRATORY TRACT INFECTION","HEADACHE","RASH"]}}